These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9422584)

  • 1. Outcome of hyperfractionated radiation therapy in randomized clinical trials.
    Willers H; Liertz-Petersen C; Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):257-9. PubMed ID: 9422584
    [No Abstract]   [Full Text] [Related]  

  • 2. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
    Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
    Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial.
    Hansen CR; Johansen J; Kristensen CA; Smulders B; Andersen LJ; Samsøe E; Andersen E; Petersen JB; Overgaard J; Grau C
    Acta Oncol; 2015; 54(9):1669-73. PubMed ID: 26206516
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radiochemotherapy in head and neck neoplasms].
    Munker R; Reitmeier M; Hartenstein R
    Strahlenther Onkol; 2000 Nov; 176(11):537-8. PubMed ID: 11143531
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evidence-based medicine (EBM) for radiation therapy--head and neck cancer].
    Sakata K
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):334-8. PubMed ID: 12669389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfractionated radiotherapy: tops or flops?
    Baumann M; Beck-Bornholdt HP
    Med Pediatr Oncol; 1999 Oct; 33(4):399-402. PubMed ID: 10491550
    [No Abstract]   [Full Text] [Related]  

  • 8. Fractionation modification: a way to increase the biological dose?
    Ang KK
    Acta Otorhinolaryngol Belg; 1999; 53(3):227-30. PubMed ID: 10635398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of accelerated hyperfractionation for head and neck cancer.
    Cummings BJ
    Acta Oncol; 1999; 38(2):131-6. PubMed ID: 10227432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
    J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated accelerated radiotherapy alone and with concomitant chemotherapy to the head and neck: treated within and outside of randomized clinical trials.
    Hehr T; Classen J; Schreck U; Glocker S; Bamberg M; Budach W
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1424-30. PubMed ID: 15050319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Radiation Therapy Oncology Group].
    Herrmann T
    Strahlenther Onkol; 1995 Apr; 171(4):244-5. PubMed ID: 7740414
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered fractionation for head and neck cancer.
    Garden AS
    Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer.
    Saunders MI; Rojas AM; Parmar MK; Dische S;
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):3-8. PubMed ID: 20394851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of relationship between change in locoregional control and change in overall survival in randomized controlled trials of modified radiotherapy in head-and-neck cancer.
    Wadsley JC; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1405-9. PubMed ID: 15590171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck cancer: altered fractionation schedules.
    Saunders MI
    Oncologist; 1999; 4(1):11-6. PubMed ID: 10337367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.
    Hassan Metwally MA; Ali R; Kuddu M; Shouman T; Strojan P; Overgaard J; Grau C
    Acta Oncol; 2015; 54(9):1673-7. PubMed ID: 26397148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.